Eisai Co Ltd (OTCPK:ESAIY)
$ 9.845 -0.039 (-0.39%) Market Cap: 11.14 Bil Enterprise Value: 10.33 Bil PE Ratio: 48.02 PB Ratio: 1.88 GF Score: 71/100

Q3 2024 Eisai Co Ltd Earnings Presentation Transcript

Feb 06, 2024 / 06:00AM GMT
Release Date Price: $10.9 (-5.05%)

Feb 06, 2024 / 06:00AM GMT
Presentation
Feb 06, 2024 / 06:00AM GMT

=====================
Corporate Participants
=====================
* Keisuke Naito
Eisai Co., Ltd. - SVP, Chief Strategy, Planning & Ecosystem Officer and Acting Global Alzheimer's Disease Officer
* Lynn D. Kramer
Eisai Co., Ltd. - VP & Chief Clinical Officer - Alzheimer's Disease and Brain Health
* Mitsuru Shomon
Eisai Co., Ltd. - VP & CFO
* Takashi Owa
Eisai Co., Ltd. - Senior VP & Chief Scientific Officer - Japan and Asia Medical Safety

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
UBS Investment Bank, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst

======

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot